F M Sacks

Author PubWeight™ 145.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997 19.93
2 A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991 6.13
3 Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999 5.12
4 A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996 3.69
5 Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001 3.56
6 Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 1999 3.26
7 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998 3.19
8 Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001 3.12
9 Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998 2.97
10 Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005 2.77
11 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991 2.68
12 Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 1992 2.68
13 Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994 2.68
14 Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 1990 2.37
15 Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999 2.30
16 Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989 2.28
17 The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr 1998 2.24
18 Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998 2.22
19 Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 1993 2.15
20 Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med 1996 2.03
21 Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997 1.88
22 Cardiovascular disease in women. Circulation 1993 1.87
23 Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr 1991 1.78
24 Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001 1.75
25 A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999 1.74
26 Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol 1998 1.67
27 Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med 1975 1.59
28 Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989 1.58
29 Chewing the fat--how much and what kind? N Engl J Med 1991 1.57
30 Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 1999 1.50
31 The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc 1999 1.40
32 Blood pressure in vegetarians. Am J Epidemiol 1974 1.40
33 Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol 1995 1.39
34 The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 2000 1.39
35 Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb 1993 1.38
36 Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med 1993 1.38
37 Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension 1999 1.14
38 Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet 1984 1.12
39 Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res 2001 1.11
40 Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc 1999 1.11
41 A prospective study of nutritional factors and hypertension among US women. Circulation 1989 1.08
42 The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol 1988 1.03
43 Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001 1.00
44 Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol 1990 0.99
45 Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Curr Med Res Opin 2010 0.97
46 Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 1994 0.97
47 Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J 2001 0.96
48 Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res 1999 0.96
49 Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost 1992 0.96
50 Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol 1999 0.96
51 Lipid-lowering therapy in acute coronary syndromes. JAMA 2001 0.94
52 Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol 1990 0.92
53 A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995 0.91
54 More on chewing the fat. The good fat and the good cholesterol. N Engl J Med 1991 0.90
55 The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol 1995 0.90
56 Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol 1992 0.89
57 Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA 1981 0.89
58 Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol 2001 0.89
59 Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol 1995 0.89
60 Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr 1987 0.88
61 Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med 1986 0.88
62 The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol 2001 0.87
63 Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension 1984 0.87
64 Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest 1993 0.86
65 Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA 1985 0.86
66 Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 1998 0.83
67 Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J Clin Pharmacol 1988 0.83
68 Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol 1995 0.83
69 Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med 1986 0.82
70 Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol 1987 0.81
71 Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study. Int J Obes (Lond) 2011 0.81
72 Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol 1999 0.81
73 Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr 1996 0.81
74 Diet type and changes in food cravings following weight loss: findings from the POUNDS LOST Trial. Eat Weight Disord 2012 0.81
75 Stability of blood pressure in vegetarians receiving dietary protein supplements. Hypertension 1984 0.80
76 Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group. Am J Cardiol 1993 0.80
77 The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am J Clin Nutr 1993 0.79
78 Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol 1989 0.79
79 Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am J Cardiol 1990 0.79
80 Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. Arteriosclerosis 1987 0.78
81 Effects of inherent responsiveness to diet and day-to-day diet variation on plasma lipoprotein concentrations. Am J Clin Nutr 1996 0.78
82 Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol. J Clin Endocrinol Metab 1999 0.78
83 Premature coronary deaths in Asians. BMJ 1996 0.78
84 A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100. Arterioscler Thromb 1993 0.77
85 Dietary approaches to stop hypertension. Ann Epidemiol 1995 0.77
86 Comparison of the absorption and effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil. Am J Clin Nutr 1991 0.76
87 Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1993 0.76
88 Patch up the menopause. Lancet 1988 0.76
89 A trilogy of primary prevention statin trials. Panel discussion. Atheroscler Suppl 2007 0.75
90 Desirable serum total cholesterol with low HDL cholesterol levels. An undesirable situation in coronary heart disease. Circulation 1992 0.75
91 Threshold level or not for low-density lipoprotein cholesterol. Am J Manag Care 2001 0.75
92 Should separate endpoint trials be required for all lipid-lowering drugs acting by the same mechanism? Am J Cardiol 1998 0.75
93 Dietary fats and blood pressure: a critical review of the evidence. Nutr Rev 1989 0.75
94 Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology 1996 0.75
95 Effects of foods consumed on plasma cholesterol levels. Am J Clin Nutr 1983 0.75
96 Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians. An experiment and a critical review. J Lipid Res 1983 0.75
97 Eggs and cholesterol. Lancet 1984 0.75
98 Special report: cardiovascular disease in women. Special writing group. Heart Dis Stroke 1994 0.75